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Childhood-onset schizophrenia (COS; deﬁned as onset by
age 12 years) is rare, difﬁcult to diagnose, and represents
a severe and chronic phenotype of the adult-onset illness. A
study of childhood-onset psychoses has been ongoing at the
National Institute of Mental Health (NIMH) since 1990,
where children with COS and severe atypical psychoses
(provisionally labeled ‘‘multidimensionally impaired’’ or
MDI by the NIMH team) are studied prospectively along
with all ﬁrst-degree relatives. COS subjects have robust
cortical gray matter (GM) loss during adolescence, which
appears to be an exaggeration of the normal cortical
GM developmental pattern and eventually mimics the
pattern seen in adult-onset cases as the children become
young adults. These cortical GM changes in COS are
diagnostically speciﬁc and seemingly unrelated to the
effects of medications. Furthermore, the cortical GM
loss is also shared by healthy full siblings of COS pro-
bands suggesting a genetic inﬂuence on the abnormal brain
development.
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Introduction
Across medicine, childhood manifestation of a typical
adult-onset illness usually shows a more severe pheno-
type and perhaps greater genetic influences.
1 This also
appears to be the case in childhood-onset schizophrenia
(COS), which is a rare, severe phenotype of the typical
adult-onset illness.
2 Although the existence of childhood
schizophrenia was recognized since early in the 20th cen-
tury,
2,3 ‘‘childhood psychosis’’ broadly included both the
spectrum of behavioral disorders as well as autism
4 until
these were distinguished by Kolvin
5 in 1971. Even today,
high rates of misdiagnosis remain because transient psy-
chotic symptoms can occur in healthy children
6–8 and
fleeting hallucinations are not uncommon in nonpsy-
chotic pediatric patients,
9,10 particularly in response to
anxiety and stress.
11 Fully developed psychotic disorders
in children, however, are rare and tend to be more severe
than their adult counterparts,
1 and recent data from
a large birth cohort study suggests that self-reported
psychotic symptoms at age 11 years predicted a very
high risk (odds ratio = 16.4, confidence interval = 3.9–
67.8) of schizophreniform diagnosis at age 26 years
suggesting that psychotic symptoms probably exist as
a continuous phenotype rather than an all-or-none
phenomenon.
12
A study of COS was started at the National Institute o
Mental Health (NIMH) in 1990 with the hypothesis that
it would make it possible to study the illness with a more
homogeneous phenotype, closer to the developmental
roots, and also less confounded by environmental factors
such as multiple hospitalizations or substance abuse.
Over the past 15 years, children have been nationally
recruited and diagnosis is made using unmodified Diag-
nostic and Statistical Manual of Mental Disorders, Third
Revision/Fourth Edition (DSM-IIIR/IV), criteria for
schizophrenia, with onset of psychosis by age 12 years,
premorbid IQ of 70 or above, and absence of significant
neurological disorder. In most cases, the diagnosis is con-
firmed after a complete medication washout followed by
1–3weeks’drug-freeinpatientobservation.
2,13,14Thishas
resulted in a unique homogeneous cohort of COS cases
(n = 95 to date), where most patients resemble chronic,
severe, treatment-refractory adult-onset cases. Earlier
studies comprehensively showed the continuity between
the early- and later onset schizophrenia through studies
on premorbid risk factors,
15–22 smooth pursuit eye-
tracking function,
23 familial schizophrenia-spectrum dis-
orders,
24,25 and neurocognitive measures.
26
Structural brain abnormalities are an established fea-
ture of schizophrenia, characterized by decreased total
graymatter(GM)volumereductionincortex,hippocam-
pus, and amygdala.
27–30 The cortical GM loss appears
progressive over time.
31–34 Regional analyses of cortical
GM, using either voxel-based morphometry or cortical
thickness measures, show that most cortical GM deficits
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30in schizophrenia are localized to prefrontal and superior
temporal cortices in both first-episode and chronic adult
patients.
35–37 However, many questions regarding the
GM findings remain unanswered; eg, whether the GM
changes are genetically influenced, whether the GM
loss could be considered a trait marker, what is the influ-
ence of medications on GM changes, whether the GM
loss is functionally significant, and whether the GM
changes in schizophrenia are diagnostically specific.
The unique cohort of severe but homogeneous COS
cases, along with their healthy as well as schizophre-
nia-spectrum full siblings, provide an important sample
to gain further insights into some of these questions,
which are discussed in this review.
Brain Imaging Studies in COS
The majority of the COS brain imaging studies have
come from the NIMH cohort. Earlier cross-sectional im-
aging studies showed general agreement on findings of
increased lateral ventricular volume, decreased total as
wellasregionalGMvolumes,andincreasedbasalganglia
volume.
38–44 Later on, prospective longitudinal brain
magnetic resonance imaging (MRI) studies of the
NIMH COS population showed increasing ventricular
volume anddecreasing totalcortical, frontal,medial tem-
poral, and parietal GM volumes at 2- to 6-year follow-
up
39,45 during adolescent years.
However, all these early studies were done using rela-
tively crude whole-lobe volumetric measures that do not
provide subregional specificity of GM findings. Recent
advances in computational image analysis now permit re-
gional GM density or cortical thickness measurements,
which, when automated, can be applied to large samples,
increasing statistical power
46–48 and provide unprece-
dented anatomic detail of cortical GM change across
the entire cortex, and across time.
49 Using these novel
brain mapping techniques, we now have mapped longi-
tudinal GM developmental trajectories for COS pro-
bands contrasting them with matched groups of
healthy children, healthy COS siblings, and children
with pediatric bipolar illness to address some of the ques-
tions raised above.
What is the Pattern of Cortical GM Loss in COS? And
HowDoestheGMLossinCOSCompareWiththeNormal
GM Maturation Pattern?
Initial analyses on 12 COS patients and temporally
matched controls with prospective scans over 5 years be-
tween showed a unique wave of ‘‘back-to-front’’ tissue
loss with early parietal GM loss followed by frontal
and temporal GM loss (parietofrontal and parieto-





In a recent analyses of 13 healthy children with 3–5
scans (n = 54 scans) over a 10-year period (ages 4–22
years),
49 an overall similar pattern of GM maturation
was seen also progressing in ‘‘back-to-front’’ or parieto-
frontal and parietotemporal directions. This suggests
that GM loss in COS may reflect an exaggeration of
normal maturational process of synaptic/dendritic
pruning during adolescence,
52,53 perhaps also supporting
the excessive pruning (synaptic elimination) hypothesis




Several adult schizophrenia studies using brain MRI
have reported GM loss and ventricular enlargement,
which are progressive.
31–33,55–59 Because adolescence is
a time for major brain reorganization, we hypothesized
that the GM changes in COS will be more striking
than seen in the adult population with the illness, which
could be either the cause or result of the more severe COS
phenotype. An effect size comparison of longitudinal an-
atomic MRI studies showed that the progressive brain
changes in COS are indeed more robust than in the
adult-onset schizophrenia (AOS) population.
60 This
may also indicate either a ‘‘pathological hit’’ in early
childhood, or that in adult-onset patients, the disease
process could have begun during adolescence, prior to
the onset of psychosis, as suggested recently by Pantelis
et al.
61
Does the Cortical GM Loss in COS Mimic the
Aadult-Onset Pattern After Adolescence?
If COS is continuous with AOS, as the children become
young adults, the cortical GM pattern would take the
pattern seen in AOS patients. Cortical thickness analyses
in AOS show GM loss mostly in prefrontal and temporal
cortices.
36,46 In seeking whether COS eventually resem-
bles the pattern seen in AOS, we analyzed GM develop-
ment using prospective MRI scans of 70 COS subjects,
ages 6–26 years, and 72 matched healthy controls (1–5
scans per subject; total scans = 330), using a fully auto-
mated cortical thickness analyses with mixed effect re-
gression model statistics. The analyses show that as
COSsubjectsmature,therobustandglobalGMlossdur-
ing the adolescent years becomes limited to prefrontal
and superior temporal cortices by age 24 years, mimick-
ing a pattern seen in adult patients.
35,62,63 These findings
also establish the anatomic continuity between the 2 phe-
notypes (figure 2).
Is the Cortical GM Loss Medication Inﬂuenced and
Diagnostically Speciﬁc?
How the effect of medications reflects on the pattern of
GM loss in schizophrenia has been difficult to elucidate.
35
Insights from Brain Imaging in Childhood Onset Schizophrenia
31Due to the severity of illness, medication-naive COS
subjects are difficult to obtain. We have attempted to
address this question using a cohort of atypical psychoses
patients recruited and characterized during the course of
the NIMH COS study.
The Multidimensionally Impaired Cohort. A sizeable,
heterogeneous group of children who were referred to
the study with initial diagnosis of COS were ruled out
as having COS after medication washout. These children
could not be adequately characterized into any existing




at approximate 3-year intervals for middle 80% of the age range, and colors represent areas of statistically significant thinning in COS.81






ofcorticalGMmaturationinCOSbetweenages12and16yearscomparedwith age-andsex-matchedhealthycontrols(n 5 12,36scansin
eachgroup),wherechildrenarerescannedevery2years.DynamicmapsrepresentPvaluesforthedifferenceinGMamountbetweenCOSand
controlsateachofthe65 536corticalpoints,andPvaluesarerepresentedusingacolorscale(eg,pink,P<.00002).CorticalGMlossinCOS
also appears to follow in a ‘‘back-to-front’’ direction on the lateral surface, thus suggesting that the COS pattern is an exaggeration of the
normalGMmaturation.50Asteriskrepresentsdataonchildhoodschizophreniaonlyage12–16years.AdaptedfromProcNatlAcadSciUSA
2004;101:8178 and Proc Natl Acad Sci USA 2001;98:11652.
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N. GogtayDSM-IV diagnoses
13,64,65 (would probably be labeled
psychosis not otherwise specified [NOS] or mood disor-
der NOS) and were labeled by the NIMH group as ‘‘mul-
tidimensionally impaired (MDI),’’ due to the following
distinct features which were used as the ‘‘operational di-
agnosticcriteria’’bytheNIMHgroup
13,64:(1)brief,tran-
sient episodes of psychosis and perceptual disturbance
usually in response to stress (as opposed to the pervasive
hallucinations/delusions in COS); (2) nearly daily periods
of emotional lability disproportionate to participitants,
(3) impaired interpersonal skills despite the desire to ini-
tiate peer friendships (distinction from COS), (4) no
thought disorder, and (5) high comorbidity with atten-
tion-deficit/hyperactivity disorder. These children were
followed longitudinally along with the COS children
with the thought that some of the MDI children may
evolve into the schizophrenia spectrum,
64 but at 2- to
10-year follow-up the MDI cohort appears to have a dis-
tinct long-term clinical course and none have progressed
to schizophrenia.
66 Due to their similar initial presenta-
tionandmedicationhistory,thesechildrenhaveprovided
a medication-matched contrast group to evaluate the
specificity of brain findings in COS.
When progressive GM changes were mapped in
a group of age-, sex-, and IQ-matched COS (n = 12)
and ‘‘MDI’’ (n = 10) patients, it was clear that the corti-
cal deficits seen in COS are not shared by the ‘‘MDI’’
groupandthusarenotaresultofmedicationtreatment.
50
This is further supported by our recent quantitative anal-
ysis of a larger sample of matched COS (n = 23), ‘‘DI’’
(n = 19) and healthy community control (n = 38) groups,
where the GM loss was specifically seen in COS group.
67
At 4- to 8-year follow-up, 12 out of 32 MDI subjects
(38%) developed a DSM-IV–defined manic episode and
thus were diagnosed as Bipolar I. Nine of these 12 chil-
drenhadusablescans thatwere obtainedbeforeand after
the first manic episode (Bipolar I diagnosis). We mapped
the cortical brain development in pediatric bipolar illness
before and after the onset of illness. These analyses show
a pattern strikingly distinct from that seen in COS. The
brain development in MDI children who became Bipolar
I showed subtle, regionally specific, bilaterally asymmet-
rical cortical changes, with cortical GM increasing over
the left temporal cortex and decreasing bilaterally in the
anterior (and subgenual) cingulate cortex particularly af-
ter the illness onset.
68 Thus, at least in pediatric samples,
there appears to be no overlap between the brain changes
in COS and bipolar illness.
Is the Increased GM Loss in COS Genetically Inﬂuenced
and a Trait Marker?
Several studies have describedstructural brain abnormal-
ities in families of schizophrenic patients.
69–72 Our initial
cross-sectional analysis with 15 healthy full siblings of
COS (mean age 19.4 6 5.9 years) showed GM reduction
relativeto32healthycontrols(meanage18.7 6 6.2years),
where the difference was most significant in the parietal
GM (effect size = 0.3).
73 This was recently explored
further using automated cortical thickness analyses on
anexpandedsampleofnonpsychoticsiblingsofCOSpro-
bands(n = 52, 113 scans; age 8–28 years) contrasting with
age-,sex-,andscaninterval–matchedcontrols(n = 52,108





COS may be familial/trait markers. However, the cortical
deficits in siblings disappeared by age 20 years suggesting
aplasticorrestitutivebrainresponseinthesenonpsychotic,
nonspectrum siblings (figure 3).
75
Fig. 3. Cortical Gray Matter (GM) Thickness in Healthy Childhood-Onset Schizophrenia (COS) Siblings (n 5 52, 110 scans) Compared
WithAge-,Sex-,andScanInterval–MatchedHealthyControls(n 5 52,108scans)BetweenAges8Through28Years.HealthyCOSsiblings
show significant GM deficits in left prefrontal and bilateral temporal cortices and smaller deficits in right prefrontal and inferior parietal
cortices.Thesedeficitsinhealthysiblingsnormalizewithagewithnoabnormalitiesremainingbyage20years.Sidebarshowststatisticwith
threshold to control for multiple comparisons using the false discovery rate procedure with q 5 0.05. Differences are from mixed model
regression with age centered at approximate 3-year intervals for middle 80% of the age range, and colors represent areas of statistically
significant thinning in COS siblings. Adapted from Arch Gen Psychiatry. 2007;64:774.
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Insights from Brain Imaging in Childhood Onset SchizophreniaNumerous chromosomal abnormalities have been
reported in schizophrenia.
75,76 As has been seen in
other pediatric onset diseases,
1,77,78 the familial risk
for schizophrenia-spectrum disorders appear higher for
COS than for AOS.
24,25 Candidate gene association
studies and cytogenetic studies also show increased rates
of abnormalities for the COS population, which are
clearly higher than those seen for the AOS.
79
We are beginning to explore the influence of individ-
ual risk alleles on GM developmental trajectories. For
example, the gene for glutamate decarboxylase (GAD),
a modulator enzyme for the inhibitory neurotransmitter
c-aminobutyric acid, influences the prefrontal cortical
circuitry and postmortem studies have shown reduction
in prefrontal cortical GM in schizophrenia patients with
GAD risk gene.
80,81 Our preliminary analyses using au-
tomated cortical thickness measures show that, in both
COS subjects (n = 61, 149 scans) and their healthy sib-
lings (n = 24, 50 scans), presence of GAD risk allele is
associated with steeper slopes for GM loss in prefrontal
and parietal cortices most prominently on the left side;
while a similar analysis in the controls (n = 232, 500
scans) revealed no influence of the risk allele status
(DrNitinGogtay,unpublisheddata).Theseobservations
strongly suggest that the GM changes in COS are genet-
ically influenced, possibly trait markers (at least in pre-
frontal and temporal regions), and influenced by risk
allele status.
Is there a Relationship Between Brain Developmental
Abnormalities and Functional Outcome?
The clinical and functional implications of cortical GM
lossinschizophreniahavebeen unclear.Wehaverecently
studied this relationship in both COS probands and their
healthy siblings. In healthy COS siblings, where the cor-
tical GM deficits appear in early ages and normalize by
20 years, the process of deficit reduction appears to be
correlated with overall functioning (GAS scores) at the
last scan with children with higher GAS scores showing
faster deficit reduction.
74 Similarly, in our preliminary
analyses, the COS probands who meet the criteria for re-
mission at discharge (n = 19) have thicker cortical GM in
prefrontal, temporal, as well as parietal cortical regions
compared with the non remitted (n = 53) probands (Dr
Deanna Greenstein, unpublished data). These findings
suggest a relationship between brain plasticity and func-
tional as well as clinical outcome in schizophrenia.
Summary
COS, which appears to represent more severe neurobio-
logical and phenomenological counterpart of the adult-
onset illness, follows a distinct course with more salient
genetic factors. Advances in neuroimaging and genetic
methodology, combined with the availability of longitu-
dinal data, now allow further insights into the disease on-
set, course, and etiopathologic mechanisms in COS,
which can be extended to the understanding of schizo-
phrenia pathology at large. However, research in this
field is still limited by small samples and few longitudinal
and population-based studies stressing the need for con-
tinued future work in this area.
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